Pharmacopeial compliance of fish oil-containing parenteral lipid emulsion mixtures: Globule size distribution (GSD) and fatty acid analyses.
Recently, the United States Pharmacopeia (USP) has established Chapter 729 with GSD limits for all lipid emulsions where the mean droplet size (MDS) must be <500 nm and the percent of fat larger than 5 microm (PFAT(5)) must be <0.05%, irrespective of the final lipid concentration. As well, the European Pharmacopeia (EP) Monograph no. 1352 specifies n3-fatty acid (FA) limits (EPA+DHA> or =45%; total n3 or T-n3> or =60%) for fish oil. We assessed compliance with USP physical and EP chemical limits of two fish oil-containing lipid emulsion mixtures. All lipid emulsions passed USP 729 limits. No samples tested had an MDS >302 nm or a PFAT(5) value >0.011%. Only one product met EP limits while the other failed. All emulsions tested were extremely fine dispersions and easily met USP 729 GSD limits. The n3-FAs profiles were lower in one, despite being labeled to contain 50% more fish oil than the other product. This latter finding suggests the n3-FA content of the fish oil source and/or the applied manufacturing processes in these products is different.
Driscoll
David F
DF
Nutrition/Infection Laboratory, Department of Medicine, B.I. Deaconess Medical Center and Harvard Medical School, Boston, MA, USA. d.driscoll.ssi@gmail.com
Ling
Pei-Ra
PR
Bistrian
Bruce R
BR
D005060:Europe; D005217:Fat Emulsions, Intravenous / Q000737:chemistry / Q000592:standards*; D015525:Fatty Acids, Omega-3 / Q000737:chemistry / Q000592:standards*; D005395:Fish Oils / Q000737:chemistry / Q000592:standards*; D019983:Guideline Adherence; D010602:Pharmacopoeias as Topic; D014481:United States
D005217:Fat Emulsions, Intravenous; D015525:Fatty Acids, Omega-3; D005395:Fish Oils